Data / Form D filings / PROTEON THERAPEUTICS INC
PROTEON THERAPEUTICS INC: Form D filings
PROTEON THERAPEUTICS INC, a biotechnology company in Waltham, MA, filed 4 Form D notices with the SEC between 2011 and 2017. The latest, on August 16, 2017, reports $22 million sold of a $22 million offering to 11 investors.
Find out what PROTEON THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 WEST STREET, Waltham, MA, 02451
- Phone
- (781) 890-0102
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1359931
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 16, 2017 | New notice | $22,000,000 | $22,000,000 | $0 | 11 | Aug 2, 2017 | sec.gov |
| May 28, 2014 | New notice | $29,565,934 | $29,565,934 | $0 | 22 | May 13, 2014 | sec.gov |
| Feb 19, 2014 | New notice | $4,338,660 | $4,338,660 | $0 | 17 | Sep 4, 2013 | sec.gov |
| Aug 11, 2011 | New notice | $15,183,371 | $15,183,371 | $0 | 19 | Aug 2, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew P. Kowalsky | Executive Officer | |
| Tony G. Kingsley | Director | |
| John G. Freund, M.D. | Director | |
| Steven K. Burke, M.D. | Executive Officer | |
| Hubert J. Birner, Ph. D. | Director | |
| Jonathan G. Leff | Director | |
| Paul J. Hastings | Director | |
| E. Scott Toner | Executive Officer | |
| Tim G. Haines | Director | |
| Timothy P. Noyes | Executive Officer, Director | |
| Scott A. Canute | Director | |
| George A. Eldridge | Executive Officer | |
| Garen J. Bohlin | Director | |
| Daniel P. Gottlieb | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Aug 14, 2017 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROTEON THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.